Billionaire activist investor Daniel Loeb describes the strategy at his Third Point hedge fund as “an event-driven and value approach.” He looks to unlock shareholder value through special situation investing, whether it is mergers and acquisitions, restructurings or other catalysts that can spur gains. Loeb started Third Point with just $3 million in 1995 and
0 Comments
In this article CB Follow your favorite stocksCREATE FREE ACCOUNT Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 4, 2024.  CNBC Warren Buffett finally revealed his secret stock pick in a new regulatory filing, and it’s insurer Chubb. His conglomerate Berkshire Hathaway has bought nearly 26 million shares
0 Comments
High-yield dividend stocks are particularly noteworthy in income investing. Seven stocks, all with yields over 7%, may spark rapid expansion in various industries. The first one is a massive real estate company specializing in cannabis operators, and it has a portfolio that spans many states and more than a hundred locations. The second one then becomes
0 Comments
It’s been nearly two weeks since Warren Buffett presided over his company’s annual shareholder meeting in Omaha. The ritual has become a must-attend for those in the industry and Berkshire Hathaway (NYSE:BRK.B) shareholders. There’s no question Berkshire Hathaway stock remains very attractive for long-term investors. The media’s gone over many of the highlights, so I
0 Comments
ExxonMobil (NYSE:XOM) recently completed its $60 billion acquisition of Pioneer Natural Resources. The deal expands the oil and gas giant’s presence in the oil-rich Permian basin. However, before the Federal Trade Commission (FTC) signed off on the transaction, Pioneer CEO Scott Sheffield was banned from taking a board seat at Exxon. It alleged Sheffield colluded
0 Comments
The biotech industry is notably risky, but can produce stocks that see massive gains within a day. How can this happen? Well, many of these companies depend on FDA approval for their drugs to enter the market. This is essential since the drug sales comprise a large portion of these companies’ revenue. However, many of
0 Comments